Central Pain after Pontine Infarction Is Associated with Changes in Opioid Receptor Binding: A PET Study with ¹¹C-Diprenorphine

References

1. ↵
   Dejérine J, Roussy G. Le syndrome thalamique. Rev Neurol 1906;12:521-532
2. ↵
   Merskey H, Lindblom U, Mumford JM, Nathan PW, Noordenbos W, Sunderland S. Pain terms: a current list with definitions and notes on usage. Pain 1986;Suppl 3:217-221
3. ↵
   Boivie J. Central pain. In: Wall PD, Melzack R, eds. Textbook of Pain. 3rd ed. New York: Churchill Livingstone; 1994:871–902
4. ↵
   De Salles AAF, Bittar GT. Thalamic pain syndrome: anatomic and metabolic correlation. Surg Neurol 1994;17:213-224
5. Chabriat H, Pappata S, Levasseur M, Fiorelli M, Tran DS, Baron JC. Cortical metabolism in posterolateral thalamic stroke: PET study. Acta Neurol Scand 1992;86:285-290

   CrossRefPubMed
6. ↵
   Jones AKP, Cunningham VJ, Ha Kawa S, et al. Changes in central opioid receptor binding in relation to inflammation and pain in patients with rheumatoid arthritis. Br J Rheumatol 1994;33:909-916

   Abstract/FREE Full Text
7. ↵
   Bartenstein P, Prevett MC, Duncan JS, Hajek M, Wieser HG. Quantification of opiate receptors in two patients with mesiobasal temporal lobe epilepsy, before and after selective amygdalohippocampectomy, using positron emission tomography. Epilepsy Res 1994;18:119-125

   CrossRefPubMedWeb of Science
8. ↵
   Frost JJ, Douglas KH, Mayberg HS, et al. Multicompartmental analysis of [¹¹C]carfentanil binding to opiate receptors in humans measured by positron emission tomography. J Cereb Blood Flow Metab 1989;9:398-409

   PubMedWeb of Science
9. ↵
   Cunningham VJ, Jones T. Spectral analysis of dynamic PET studies. J Cereb Blood Flow Metab 1993;13:15-23

   PubMedWeb of Science
10. Weeks RA, Cunningham VJ, Piccini P, Waters S, Harding AE, Brooks DJ. [¹¹C]diprenorphine binding in Huntington's disease: a comparison of region of interest analysis with statistical parametric mapping. J Cereb Blood Flow Metab 1997;17:943-949

    CrossRefPubMedWeb of Science
11. ↵
    Pietrzyk U, Herholz K, Fink G, et al. An interactive technique for three-dimensional image registration: validation for PET, SPECT, MRI and CT brain studies. J Nucl Med 1994;35:2011-2018

    Abstract/FREE Full Text
12. ↵
    Minoshima S, Koeppe RA, Frey KA, Kuhl DE. Anatomic standardization: linear scaling and nonlinear warping of functional brain images. J Nucl Med 1994;35:1528-1537

    Abstract/FREE Full Text
13. Minoshima S, Frey KA, Koeppe RA, Foster NL, Kuhl DE. A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med 1995;36:1238-1248

    Abstract/FREE Full Text
14. ↵
    Burn DJ, Rinne JO, Quinn NP, Lees AJ, Marsden CD, Brooks DJ. Striatal opioid receptor binding in Parkinson's disease, striatonigral degeneration and Steele-Richardson-Olszewski syndrome: a [¹¹C]diprenorphine PET study. Brain 1995;118:951-958

    Abstract/FREE Full Text
15. ↵
    Chesis PL, Griffeth LK, Mathias CJ, Welch MJ. Sex-dependent differences in N-(3-(F-18)fluoropropyl)-N-nordiprenorphine biodistribution and metabolism. J Nucl Med 1990;31:192-201

    PubMed
16. ↵
    Lassen NA, Bartenstein P, Lammertsma AA, et al. Benzodiazepine receptor quantification in vivo in humans using [¹¹C]flumazenil and PET: application of the steady-state principle. J Cereb Blood Flow Metab 1995;15:152-165

    PubMedWeb of Science
17. ↵
    Carter BD, Medzihradsky F. Receptor mechanisms of opioid tolerance in SH-SY5Y human neural cells. Mol Pharmacol 1993;43:465-473

    Abstract